Evidence map›Paper›PMID 34433009›Full record

ArticleAmerican journal of human genetics2021

Position effects at the FGF8 locus are associated with femoral hypoplasia.

Magdalena Socha, Anna Sowińska-Seidler, Uirá Souto Melo, Bjørt K Kragesteen, Martin Franke, Verena Heinrich, Robert Schöpflin, Inga Nagel, Nicolas Gruchy, Stefan Mundlos and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 5 countries.

Magdalena SochaDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan 60-806, Poland.
Anna Sowińska-SeidlerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan 60-806, Poland.
Uirá Souto MeloMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin 14195, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin 10117, Germany.
Bjørt K KragesteenMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin 14195, Germany; Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Martin FrankeMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin 14195, Germany; Centro Andaluz de Biología del Desarrollo, Consejo Superior de Investigaciones Científicas/Universidad Pablo de Olavide, Seville 41013, Spain.
Verena HeinrichDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Robert SchöpflinMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin 14195, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin 10117, Germany; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Inga NagelInstitute of Human Genetics, Universitätsklinikum Schleswig Holstein Campus Kiel and Christian-Albrechts-Universität, Kiel 24105, Germany.
Nicolas GruchyDepartment of Genetics, EA7450 BioTARGen, Normandie Université, UNICAEN, CHU de Caen Normandie, Caen 14000, France.
Stefan MundlosMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin 14195, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin 10117, Germany; Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin 13353, Germany.
Varun K A SreenivasanInstitute of Human Genetics, Universitätsklinikum Schleswig Holstein Campus Lübeck and University of Lübeck, Lübeck 23562, Germany.
Cristina LópezInstitut d'Investigacions Biomèdiques August Pi i Sunyer, Ciber de Cáncer, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
Martin VingronDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Ewelina Bukowska-OlechDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan 60-806, Poland.
Malte SpielmannInstitute of Human Genetics, Universitätsklinikum Schleswig Holstein Campus Kiel and Christian-Albrechts-Universität, Kiel 24105, Germany; Institute of Human Genetics, Universitätsklinikum Schleswig Holstein Campus Lübeck and University of Lübeck, Lübeck 23562, Germany; Human Molecular Genomics Group, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany. Electronic address: malte.spielmann@uksh.de.
Aleksander JamsheerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan 60-806, Poland; Centers for Medical Genetics GENESIS, Poznan 60-529, Poland. Electronic address: jamsheer@wp.pl.
Max Planck Institute for Molecular Genetics · DEPoznan University of Medical Sciences · PLBerlin-Brandenburger Centrum für Regenerative Therapien · DECentro Andaluz de Biología del Desarrollo · ESCharité - Universitätsmedizin Berlin · DEConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESKiel University · DEUniversité de Caen Normandie · FRUniversity Hospital Schleswig-Holstein · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copy-number variations (CNVs) are a common cause of congenital limb malformations and are interpreted primarily on the basis of their effect on gene dosage. However, recent studies show that CNVs also influence the 3D genome chromatin organization. The functional interpretation of whether a phenotype is the result of gene dosage or a regulatory position effect remains challenging. Here, we report on two unrelated families with individuals affected by bilateral hypoplasia of the femoral bones, both harboring de novo duplications on chromosome 10q24.32. The ∼0.5 Mb duplications include FGF8, a key regulator of limb development and several limb enhancer elements. To functionally characterize these variants, we analyzed the local chromatin architecture in the affected individuals' cells and re-engineered the duplications in mice by using CRISPR-Cas9 genome editing. We found that the duplications were associated with ectopic chromatin contacts and increased FGF8 expression. Transgenic mice carrying the heterozygous tandem duplication including Fgf8 exhibited proximal shortening of the limbs, resembling the human phenotype. To evaluate whether the phenotype was a result of gene dosage, we generated another transgenic mice line, carrying the duplication on one allele and a concurrent Fgf8 deletion on the other allele, as a control. Surprisingly, the same malformations were observed. Capture Hi-C experiments revealed ectopic interaction with the duplicated region and Fgf8, indicating a position effect. In summary, we show that duplications at the FGF8 locus are associated with femoral hypoplasia and that the phenotype is most likely the result of position effects altering FGF8 expression rather than gene dosage effects.

Indexed as

Chromosome DuplicationDNA Copy Number VariationsAdolescentAllelesAnimalsChild, PreschoolChromatinChromosomes, Human, Pair 10CRISPR-Cas SystemsEnhancer Elements, GeneticFamilyFemaleFemurFibroblast Growth Factor 8Gene EditingHeterozygoteChromatinFGF8 protein, humanFgf8 protein, mouseFibroblast Growth Factor 8enhancerfemoral hypoplasiaFGF8non-coding mutationsposition effectsTADs

Identifiers

PMID34433009
PMCPMC8456176
OpenAlexW3193474866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.